Global Health Financing Expert Discusses ‘Market Shaping’ For Global Health Products, Gavi Paper On Topic

Center for Global Development: Reflections on 15 Years of “Market Shaping”: The Case of the Pentavalent Vaccine
Rachel Silverman, a policy fellow at the Center for Global Development, discusses a paper published in the August issue of Vaccine: X, in which “former and current employees and partners of Gavi, the Vaccine Alliance reflect on their 15 years of ‘market shaping’ experience — that is, Gavi’s efforts to use its purchasing power and other tools to create more favorable market conditions — for the pentavalent vaccine (often called ‘penta’).” Silverman offers her own analysis on the broader context of procurement, concluding, “I encourage you to read the whole thing — and I urge others in the market shaping world to clearly document (and empirically evaluate!) your efforts” (9/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.